Quarterly Consolidated Statement Of Cash Flows

Medical Data Vision Co.,Ltd. - Filing #7266592

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-727,308,000 JPY
-756,840,000 JPY
1,584,102,000 JPY
1,567,922,000 JPY
Depreciation
102,032,000 JPY
48,828,000 JPY
Impairment losses
JPY
115,596,000 JPY
Amortization of goodwill
25,685,000 JPY
53,192,000 JPY
Increase (decrease) in allowance for doubtful accounts
95,569,000 JPY
28,346,000 JPY
Interest and dividend income
-846,000 JPY
-625,000 JPY
Share of loss (profit) of entities accounted for using equity method
514,670,000 JPY
72,425,000 JPY
Decrease (increase) in inventories
-16,173,000 JPY
10,765,000 JPY
Increase (decrease) in trade payables
78,161,000 JPY
47,432,000 JPY
Other, net
-78,697,000 JPY
15,251,000 JPY
Subtotal
-119,208,000 JPY
1,874,341,000 JPY
Interest and dividends received
846,000 JPY
625,000 JPY
Net cash provided by (used in) operating activities
-877,849,000 JPY
1,616,314,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-154,495,000 JPY
-30,206,000 JPY
Loan advances
-120,500,000 JPY
-30,000,000 JPY
Proceeds from collection of loans receivable
JPY
30,000,000 JPY
Other, net
-1,387,000 JPY
2,658,000 JPY
Net cash provided by (used in) investing activities
-592,972,000 JPY
-437,831,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-153,475,000 JPY
JPY
Dividends paid
-248,050,000 JPY
-228,827,000 JPY
Net cash provided by (used in) financing activities
-399,985,000 JPY
-225,264,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,870,807,000 JPY
953,218,000 JPY
Cash and cash equivalents
1,347,266,000 JPY
3,218,073,000 JPY
2,264,855,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.